These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 423976)

  • 21. Murine model for human secondary amyloidosis: genetic variability of the acute-phase serum protein SAA response to endotoxins and casein.
    McAdam KP; Sipe JD
    J Exp Med; 1976 Oct; 144(4):1121-7. PubMed ID: 978136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibronectin is an acute phase reactant in mice.
    Dyck RF; Rogers SL
    Clin Invest Med; 1985; 8(2):148-51. PubMed ID: 2421956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isolation and characterization of C-reactive protein and serum amyloid P component in the rat.
    de Beer FC; Baltz ML; Munn EA; Feinstein A; Taylor J; Bruton C; Clamp JR; Pepys MB
    Immunology; 1982 Jan; 45(1):55-70. PubMed ID: 7056568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of bacterial endotoxin on body temperature, plasma zinc and plasma concentrations of the acute-phase protein serum amyloid p component in mice.
    Poole S; Gordon AH; Baltz M; Stenning BE
    Br J Exp Pathol; 1984 Aug; 65(4):431-9. PubMed ID: 6380557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mouse C-reactive protein. Generation of cDNA clones, structural analysis, and induction of mRNA during inflammation.
    Whitehead AS; Zahedi K; Rits M; Mortensen RF; Lelias JM
    Biochem J; 1990 Feb; 266(1):283-90. PubMed ID: 2310378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum amyloid A protein and C-reactive protein in systemic amyloidosis.
    Gertz MA; Skinner M; Sipe JD; Cohen AS; Kyle RA
    Clin Exp Rheumatol; 1985; 3(4):317-20. PubMed ID: 4085162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina.
    Liuzzo G; Biasucci LM; Gallimore JR; Grillo RL; Rebuzzi AG; Pepys MB; Maseri A
    N Engl J Med; 1994 Aug; 331(7):417-24. PubMed ID: 7880233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inappropriate responses to Mycobacterium leprae infections--C reactive protein in man and serum amyloid P in mice.
    Thompson RA; Sukumaran KD; Rajagopalan K
    Clin Exp Immunol; 1985 Aug; 61(2):329-35. PubMed ID: 4042426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of STAT3 and C/EBP in cytokine-dependent expression of the mouse serum amyloid P-component (SAP) and C-reactive protein (CRP) genes.
    Ochrietor JD; Harrison KA; Zahedi K; Mortensen RF
    Cytokine; 2000 Jul; 12(7):888-99. PubMed ID: 10880233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding specificity of serum amyloid P component for the pyruvate acetal of galactose.
    Hind CR; Collins PM; Renn D; Cook RB; Caspi D; Baltz ML; Pepys MB
    J Exp Med; 1984 Apr; 159(4):1058-69. PubMed ID: 6707579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute phase reactants in inflammation and infection.
    Dowton SB; Colten HR
    Semin Hematol; 1988 Apr; 25(2):84-90. PubMed ID: 2455348
    [No Abstract]   [Full Text] [Related]  

  • 32. Serum amyloid P component and autoimmune parameters in the assessment of arthritis activity in MRL/lpr/lpr mice.
    Rordorf-Adam C; Serban D; Pataki A; Grüninger M
    Clin Exp Immunol; 1985 Sep; 61(3):509-16. PubMed ID: 3878240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro induction of hepatocyte synthesis of the acute phase reactant mouse serum amyloid P-component by macrophages and IL 1.
    Le PT; Mortensen RF
    J Leukoc Biol; 1984 Jun; 35(6):587-603. PubMed ID: 6610015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The acute phase response in gout.
    Roseff R; Wohlgethan JR; Sipe JD; Canoso JJ
    J Rheumatol; 1987 Oct; 14(5):974-7. PubMed ID: 2448456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation of two novel biochemical markers of inflammation, matrix metalloproteinase and cathepsin generated fragments of C-reactive protein, in patients with ankylosing spondylitis.
    Skjøt-Arkil H; Schett G; Zhang C; Larsen DV; Wang Y; Zheng Q; Larsen MR; Nawrocki A; Bay-Jensen AC; Henriksen K; Christiansen C; Alexandersen P; Leeming DJ; Karsdal MA
    Clin Exp Rheumatol; 2012; 30(3):371-9. PubMed ID: 22339813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum amyloid P-component levels in rheumatoid arthritis.
    Levo Y; Ehrenfeld M; Wollner S
    Isr J Med Sci; 1982 Jun; 18(6):715-7. PubMed ID: 7107210
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of serum amyloid P component level on transthyretin-derived amyloid deposition in a transgenic mouse model of familial amyloidotic polyneuropathy.
    Murakami T; Yi S; Maeda S; Tashiro F; Yamamura K; Takahashi K; Shimada K; Araki S
    Am J Pathol; 1992 Aug; 141(2):451-6. PubMed ID: 1497094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inflammatory marker mania in chronic kidney disease: pentraxins at the crossroad of universal soldiers of inflammation.
    Kalantar-Zadeh K
    Clin J Am Soc Nephrol; 2007 Sep; 2(5):872-5. PubMed ID: 17702716
    [No Abstract]   [Full Text] [Related]  

  • 39. Heart disease and the inflammatory response.
    Koenig W
    BMJ; 2000 Jul; 321(7255):187-8. PubMed ID: 10903629
    [No Abstract]   [Full Text] [Related]  

  • 40. Serum amyloid P component levels are not decreased in patients with systemic lupus erythematosus and do not rise during an acute phase reaction.
    Bijl M; Bootsma H; Van Der Geld Y; Limburg PC; Kallenberg CG; Van Rijswijk MH
    Ann Rheum Dis; 2004 Jul; 63(7):831-5. PubMed ID: 15194579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.